CONTACT INFORMATIONBIOGRAPHYCREDENTIALSPUBLICATIONSEmily Dicesare, D.O.Contact InformationPhone NumbersAppointment: (585) 341-6880A member of the University of Rochester Medical Faculty GroupgroupAn Accountable Health PartnerassignmentNot Accepting New PatientsLocationsUniversity of Rochester Medical CenterSchool of Medicine and Dentistry601 Elmwood Ave, Box 655Rochester, NY 14642Faculty AppointmentsAssistant Professor of Clinical Emergency Medicine - Department of Emergency Medicine (SMD) Patient Care SettingsEmergency Medicine, Hospital MedicineBiographyProfessional BackgroundDr. DiCesare is an assistant professor of Emergency Medicine. She obtained her undergraduate degree from Elmira College in 2002, and her Masters in Molecular Biology from New York University in 2005. She received her medical degree from Lake Erie College of Osteopathic Medicine in 2009. Dr. DiCesare completed her residency at the University of Rochester in 2012, and served as Chief Resident from 2011-2012.CredentialsSpecialtiesEducation2009DO | Lake Erie College of Osteopathic MedicinePost-doctoral Training & Residency06/24/2009 - 08/13/2012Residency in Emergency Medicine at University of Rochester Medical Center06/20/2009 - 06/23/2010Internship in Emergency Medicine at University of Rochester Medical CenterPublicationsJournal Articles5/1/2006O'Connor OA, Smith EA, Toner LE, Teruya-Feldstein J, Frankel S, Rolfe M, Wei X, Liu S, Marcucci G, Chan KK, Chanan-Khan A. "The combination of the proteasome inhibitor bortezomib and the bcl-2 antisense molecule oblimersen sensitizes human B-cell lymphomas to cyclophosphamide." Clinical cancer research : an official journal of the American Association for Cancer Research.. 2006 May 1; 12(9):2902-11. 2006O'Connor, O.A.; Toner, L.; Smith, E.; Vrhoec, R.;. "Sequencing of The Novel antifolate 10-propargyl-10-deaxaaminopterin (PDX) and Gemcitabine induces apoptosis and is markedly superior to Methotrexate (MTX) and cytarabine in murine xenograft models of human aggressive non-Hodgkin's lymphoma." Clinical Cancer Research. 2006; 12: 924-932.VIEW ALL PUBLICATIONS